Observational studyAnnals of hematology2026
Ponatinib for CML patients in routine clinical practice: the PONDEROSA study.
Thomas Schenk et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
1 paper cites it
this papercites it
Observational studyAnnals of hematology2026
Thomas Schenk et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.